CTOs on the Move

Relievant Medsystems

www.relievant.com

 
Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.relievant.com
  • 2688 Middlefield Rd Ste A
    Redwood City, CA USA 94063
  • Phone: 650.368.1000

Executives

Name Title Contact Details

Funding

Relievant Medsystems raised $36M on 10/11/2016
Relievant Medsystems raised $58M on 06/26/2018
Relievant Medsystems raised $70M on 10/29/2020

Similar Companies

TriWest Healthcare Alliance

TriWest Healthcare Alliance is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St James Plaza

Skilled nursing home providing rehabilitation, long term care, and specialized dementia care in St. James, NY

Integrated Healthcare Association

As a non-profit business league, we`re funded by the healthcare industry to make the system work better for everyone. We do this work because we envision a future where providers can focus on delivering care. Health plans can focus on serving their customers. Purchasers can feel confident they`re getting the most value for their money. And where patients can ultimately get the best possible care at an affordable price. What brings us together at IHA is our passion to create a system where patients always receive the best possible care. We leave our egos at the door. We embrace the tough conversations. And we never lose sight of driving results. United by our values of Collaboration, Candor and Impact, our dedicated team works every day in support of high-quality, efficient care for all Californians. Our 40-member board of directors includes leaders from health plans, physician organizations, hospitals, health systems, purchasers, consumer groups, universities, and pharmaceutical and technology companies.

T3D Therapeutics

T3D Therapeutics` mission is to develop its lead drug product candidate, T3D-959, as a potential `First-in-Class`and `Best-in-Class` disease-modifying, breakthrough medicine for the treatment of Alzheimer`s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D=959 and has initiated pre-clinical studies in Huntington’s Disease models.